GAIL CALVERT: Open Payments
NPI 1922690254 · BROOKFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 29 payments from 8 companies in 2025. Trend: 2023 $493 · 2024 $345 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $136 |
| Viatris Specialty LLC | 6 | $116 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| ABBVIE INC. | 2 | $41 |
| Verona Pharma, Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
Products named: CAPLYTA, YUPELRI, INGREZZA, AUSTEDO XR, Ohtuvayre, IMBRUVICA, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across MO — which companies pay providers there.
